Bretisilocin: Difference between revisions
CSV import |
CSV import |
||
| Line 1: | Line 1: | ||
{{Short description|A chemical compound related to the | {{Short description|A chemical compound related to the class of tryptamines}} | ||
'''Bretisilocin''' is a | '''Bretisilocin''' is a synthetic compound that belongs to the class of [[tryptamines]], which are a group of monoamine alkaloids found in various plants, fungi, and animals. Tryptamines are structurally similar to the neurotransmitter [[serotonin]] and are known for their psychoactive properties. | ||
==Structure | ==Chemical Structure== | ||
[[File:5-F-MET.svg| | [[File:5-F-MET.svg|Chemical structure of Bretisilocin|thumb|right]] | ||
Bretisilocin is characterized by its | Bretisilocin is characterized by its indole ring structure, which is a common feature of tryptamines. The compound is a derivative of the naturally occurring tryptamine, modified by the addition of various functional groups that alter its pharmacological properties. | ||
== | ==Pharmacology== | ||
Bretisilocin | Bretisilocin acts primarily on the [[serotonin receptor|serotonin receptors]] in the brain. It is known to have a high affinity for the 5-HT2A receptor, which is believed to be responsible for its psychoactive effects. The interaction with these receptors can lead to altered perception, mood, and cognition. | ||
== | ==Synthesis== | ||
Bretisilocin | The synthesis of Bretisilocin involves several steps, starting from the basic indole structure. The process typically includes the introduction of specific substituents at designated positions on the indole ring to achieve the desired pharmacological profile. The synthesis requires careful control of reaction conditions to ensure the correct stereochemistry and purity of the final product. | ||
== | ==Potential Uses== | ||
While Bretisilocin is primarily studied for its psychoactive properties, there is ongoing research into its potential therapeutic applications. These include the treatment of certain psychiatric disorders such as [[depression]], [[anxiety]], and [[post-traumatic stress disorder]] (PTSD). However, more research is needed to fully understand its efficacy and safety profile. | |||
== | ==Legal Status== | ||
The legal status of Bretisilocin varies by country. In many jurisdictions, it is classified as a controlled substance due to its psychoactive effects and potential for abuse. Researchers must obtain special licenses to study the compound in a laboratory setting. | |||
[[Category: | ==Related Compounds== | ||
[[Category: | Bretisilocin is related to other tryptamines such as [[psilocybin]], [[DMT]], and [[5-MeO-DMT]]. These compounds share similar structural features and pharmacological effects, although each has unique properties that influence their use and regulation. | ||
[[Category: | |||
==Related pages== | |||
* [[Tryptamine]] | |||
* [[Serotonin]] | |||
* [[Psychoactive drug]] | |||
* [[Neurotransmitter]] | |||
[[Category:Tryptamines]] | |||
[[Category:Psychoactive drugs]] | |||
[[Category:Serotonin receptor agonists]] | |||
Latest revision as of 06:11, 5 March 2025
A chemical compound related to the class of tryptamines
Bretisilocin is a synthetic compound that belongs to the class of tryptamines, which are a group of monoamine alkaloids found in various plants, fungi, and animals. Tryptamines are structurally similar to the neurotransmitter serotonin and are known for their psychoactive properties.
Chemical Structure[edit]
Bretisilocin is characterized by its indole ring structure, which is a common feature of tryptamines. The compound is a derivative of the naturally occurring tryptamine, modified by the addition of various functional groups that alter its pharmacological properties.
Pharmacology[edit]
Bretisilocin acts primarily on the serotonin receptors in the brain. It is known to have a high affinity for the 5-HT2A receptor, which is believed to be responsible for its psychoactive effects. The interaction with these receptors can lead to altered perception, mood, and cognition.
Synthesis[edit]
The synthesis of Bretisilocin involves several steps, starting from the basic indole structure. The process typically includes the introduction of specific substituents at designated positions on the indole ring to achieve the desired pharmacological profile. The synthesis requires careful control of reaction conditions to ensure the correct stereochemistry and purity of the final product.
Potential Uses[edit]
While Bretisilocin is primarily studied for its psychoactive properties, there is ongoing research into its potential therapeutic applications. These include the treatment of certain psychiatric disorders such as depression, anxiety, and post-traumatic stress disorder (PTSD). However, more research is needed to fully understand its efficacy and safety profile.
Legal Status[edit]
The legal status of Bretisilocin varies by country. In many jurisdictions, it is classified as a controlled substance due to its psychoactive effects and potential for abuse. Researchers must obtain special licenses to study the compound in a laboratory setting.
Related Compounds[edit]
Bretisilocin is related to other tryptamines such as psilocybin, DMT, and 5-MeO-DMT. These compounds share similar structural features and pharmacological effects, although each has unique properties that influence their use and regulation.
